Read this company snapshot
Daily valuation snapshot
Immuron Limited American Depositary Shares: source evidence dated 2026-10-09.
- Daily close (USD)
- $1.08
- Market capitalization (USD)
- $8,716,898.19
- Price / earnings (TTM)
- Not reported
- Price / book
- 1.13
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research IMRN in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research IMRN in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for digestive tract protection; and Protectyn, an immune supplement to help maintain a healthy digestive function and liver. It also develops Travelan (IMM-124E), which is in Phase II clinical trial, to reduce the risk of contracting travelers' diarrhea; and IMM-529, which is in Phase II clinical trial, for treating patients suffering from recurring clostridium difficile infection. In additon, the company develops IMM-986, that is in pre-clinical stage. Further, it offers technology platform. The company has a collaboration with the US Naval Medical Research Command and Silver Spring, MD, USA to develop and clinically evaluate a therapeutic targeting Campylobacter and enterotoxigenic Escherichia coli infections; and a research collaboration with the Walter Reed Army Institute of Research to develop three Shigella-specific therapeutic products. The company was formerly known as Anadis Limited and changed its name to Immuron Limited in December 2008. Immuron Limited was incorporated in 1994 and is headquartered in Carlton, Australia.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing IMRN with another company.
Scroll sideways to compare all columns. Select a heading to sort.
| Daily close (USD) | $1.08 |
| Market capitalization (USD) | $8,716,898.19 |
| Price / earnings (TTM) | Not reported |
| Price / book | 1.13 |
No matching rows. Clear the filter to see all records.
Read IMRN's valuation metrics
Company size
Immuron Limited American Depositary Shares's recorded market capitalization is $8,716,898.19. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
IMRN's recorded price-to-book ratio is 1.13. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Immuron Limited American Depositary Shares with Aurora
Use the snapshot above to ask a specific question about IMRN. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow IMRN's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.